Logo

Invitrogen's License of Harvard Chemistry Topped Most-Read GenomeWeb Daily News Stories Last Week

Dec 17, 2007
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 14.
 
1. Invitrogen Licenses Harvard's Click Chemistry Technology for Cell-Based Assays (from Dec. 10)
 
2. Gene Logic Shareholders OK Sale of Genomic Business, Name Change (from Dec. 11)
 
3. NIH to Grant $43M in FY 2009 Under Shared Instruments Program (from Dec. 10)
 
4. FDA Relabels Carbamazepine to Recommend Genetic Test for Risk of Skin Reactions (from Dec. 12)
 
5. Harvard Bio Gets $5 Per Share Buyout Offer from Investor (from Dec. 14)
Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.